These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 11349693)

  • 1. Smith-Lemli-Opitz syndrome.
    Martin A; Koenig K; Scahill L; Tierney E; Porter FD; Nwokoro NA
    J Am Acad Child Adolesc Psychiatry; 2001 May; 40(5):506-7. PubMed ID: 11349693
    [No Abstract]   [Full Text] [Related]  

  • 2. Cholesterol supplementation in Smith-Lemli-Opitz syndrome.
    Abuelo DN
    Am J Med Genet; 1998 Jul; 78(4):378-80. PubMed ID: 9714443
    [No Abstract]   [Full Text] [Related]  

  • 3. Cholesterol supplementation does not improve developmental progress in Smith-Lemli-Opitz syndrome.
    Sikora DM; Ruggiero M; Petit-Kekel K; Merkens LS; Connor WE; Steiner RD
    J Pediatr; 2004 Jun; 144(6):783-91. PubMed ID: 15192627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smith-Lemli-Opitz syndrome: thirty-year follow-up of "S" of "RSH" syndrome.
    Pauli RM; Williams MS; Josephson KD; Tint GS
    Am J Med Genet; 1997 Jan; 68(3):260-2. PubMed ID: 9024556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesterol supplementation objectively reduces photosensitivity in the Smith-Lemli-Opitz syndrome.
    Azurdia RM; Anstey AV; Rhodes LE
    Br J Dermatol; 2001 Jan; 144(1):143-5. PubMed ID: 11167696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of Smith-Lemli-Opitz Syndrome, defect of cholesterol biosynthesis.
    Domizio S; Pallotta R; Romanelli A; Puglielli C; Pollice R; Casacchia M; Conte E; Domizio R; Sabatino G
    Int J Immunopathol Pharmacol; 2006; 19(2):439-42. PubMed ID: 16831310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral phenotype of RSH/Smith-Lemli-Opitz syndrome.
    Tierney E; Nwokoro NA; Kelley RI
    Ment Retard Dev Disabil Res Rev; 2000; 6(2):131-4. PubMed ID: 10899806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal apo E genotype is a modifier of the Smith-Lemli-Opitz syndrome.
    Witsch-Baumgartner M; Gruber M; Kraft HG; Rossi M; Clayton P; Giros M; Haas D; Kelley RI; Krajewska-Walasek M; Utermann G
    J Med Genet; 2004 Aug; 41(8):577-84. PubMed ID: 15286151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smith-Lemli-Opitz syndrome: treatment with cholesterol and bile acids.
    Ullrich K; Koch HG; Meschede D; Flotmann U; Seedorf U
    Neuropediatrics; 1996 Apr; 27(2):111-2. PubMed ID: 8737829
    [No Abstract]   [Full Text] [Related]  

  • 10. Partial rescue of retinal function and sterol steady-state in a rat model of Smith-Lemli-Opitz syndrome.
    Fliesler SJ; Vaughan DK; Jenewein EC; Richards MJ; Nagel BA; Peachey NS
    Pediatr Res; 2007 Mar; 61(3):273-8. PubMed ID: 17314682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biochemical diagnosis of Smith-Lemli-Opitz syndrome in a patient with congenital adrenal hyperplasia].
    GarcíaFuentes E; icioso Recio MV ; del Castillo Acedo Del Olmo E ; atas Jurado MM ; Arana Agüera M ; López López J
    An Esp Pediatr; 2000 Nov; 53(5):482-7. PubMed ID: 11141372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smith-Lemli-Opitz syndrome: the first malformation syndrome associated with defective cholesterol synthesis.
    Battaile KP; Steiner RD
    Mol Genet Metab; 2000; 71(1-2):154-62. PubMed ID: 11001806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical effects of cholesterol supplementation in six patients with the Smith-Lemli-Opitz syndrome (SLOS).
    Elias ER; Irons MB; Hurley AD; Tint GS; Salen G
    Am J Med Genet; 1997 Jan; 68(3):305-10. PubMed ID: 9024564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smith-Lemli-Opitz syndrome: a treatable inherited error of metabolism causing mental retardation.
    Nowaczyk MJ; Whelan DT; Heshka TW; Hill RE
    CMAJ; 1999 Jul; 161(2):165-70. PubMed ID: 10439827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smith-Lemli-Opitz syndrome: biochemical before clinical diagnosis; early dietary management.
    Nwokoro NA; Hyde B; Mulvihill JJ
    Am J Med Genet; 1994 May; 50(4):375-6. PubMed ID: 8209919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Smith-Lemli-Opitz syndrome and other sterol disorders.
    Svoboda MD; Christie JM; Eroglu Y; Freeman KA; Steiner RD
    Am J Med Genet C Semin Med Genet; 2012 Nov; 160C(4):285-94. PubMed ID: 23042642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a novel DHCR7 mutation in a Korean patient with Smith-Lemli-Opitz syndrome.
    Jong Hee Chae ; Ki Joong Kim ; Yong Seung Hwang ; Ki CS; Kim JW
    J Child Neurol; 2007 Nov; 22(11):1297-300. PubMed ID: 18006960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smith-Lemli-Opitz syndrome: case report and literature review.
    Danzer E; Schier F; Giggel S; Bondartschuk M
    J Pediatr Surg; 2000 Dec; 35(12):1840-2. PubMed ID: 11101752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal cholesterol biosynthesis in the Smith-Lemli-Opitz syndrome.
    Salen G; Tint GS; Xu G; Batta AK; Irons M; Elias ER
    Ital J Gastroenterol; 1995 Dec; 27(9):506-8. PubMed ID: 8919321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Congenital malformations of the genitourinary tract in children with Smith-Lemli-Opitz syndrome].
    Wolski JK; Krajewska-Walasek M; Szymkiewicz C
    Wiad Lek; 1998; 51 Suppl 3():129-33. PubMed ID: 9814122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.